Matches in SemOpenAlex for { <https://semopenalex.org/work/W2767563585> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W2767563585 endingPage "vi88" @default.
- W2767563585 startingPage "vi88" @default.
- W2767563585 abstract "In primary central nervous system lymphoma (PCNSL), L265P mutation of the myeloid differentiation 88 (MYD88) protein is the most common, and induces a constitutive activation of IRAK4 kinase, IRAK1 phosphorylation and increased NF-kB signaling, offering a unique window for therapeutic development. We previously show that AZ1495, a potent inhibitor of IRAK4, significantly delayed progression and improved OS in L265P-mutated PCNSL models [ASH 2016], highlighting the clinical potential of IRAK inhibition. In the clinic however, early monitoring of such targeted therapies remains challenging using conventional imaging, as treatment often results in non-readily detectable anatomical changes. Here, we questioned the potential of a new neuroimaging method, hyperpolarized 13C magnetic resonance spectroscopic imaging (HP-13C MRSI), to non-invasively monitor IRAK inhibition in PCNSL for the first time. Two PCNSL patient-derived xenografts models were studied: one harboring the L265P MYD88 mutation (MYD88mut), and the other, wild type for this protein (MYD88wt). Using HP-13C MRSI, a high production of HP [1-13C] lactate was detected in both MYD88wt and MYD88mut (0.5 ± 0.04, n=2 MYD88wt; 0.61 ± 0.2, n=4 MYD88mut), indicating PCNSL presence throughout the brain. At day 2 and 4 of AZ1495 treatment, the HP [1-13C] lactate-to-pyruvate ratio remains unchanged in MYD88wt animals at all treatment time points (p=0.29 and p=0.29 at day 2 and 4 when compared to baseline, respectively) On the other hand, this ratio significantly decreased in MYD88mut animals at all time points (36.6% at day 2, p=0.07 and 56.3% at day 4, p=0.0006), in line with the previously reported effect of AZ1495 treatment on MYD88mut PCNSL only. To conlude, we showed that HP-13C MRSI can detect MYD88-mutation-specific modulations of HP lactate production following IRAK inhibition. Because HP-13C MRSI is clinically translatable and expanding rapidly, this study is of high significance for future clinical trials, to enhance monitoring of PCNSL progression and response of targeted therapies." @default.
- W2767563585 created "2017-11-17" @default.
- W2767563585 creator A5002206377 @default.
- W2767563585 creator A5005822663 @default.
- W2767563585 creator A5010517370 @default.
- W2767563585 creator A5035319804 @default.
- W2767563585 creator A5040186229 @default.
- W2767563585 creator A5053437075 @default.
- W2767563585 creator A5060028789 @default.
- W2767563585 creator A5060120275 @default.
- W2767563585 creator A5061712364 @default.
- W2767563585 creator A5063781367 @default.
- W2767563585 creator A5088787388 @default.
- W2767563585 date "2017-11-01" @default.
- W2767563585 modified "2023-10-16" @default.
- W2767563585 title "EXTH-71. HYPERPOLARIZED [1-13C] PYRUVATE AS A BIOMARKER FOR TREATMENT MONITORING IN LYMPHOMA MURINE MODELS" @default.
- W2767563585 doi "https://doi.org/10.1093/neuonc/nox168.362" @default.
- W2767563585 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5692890" @default.
- W2767563585 hasPublicationYear "2017" @default.
- W2767563585 type Work @default.
- W2767563585 sameAs 2767563585 @default.
- W2767563585 citedByCount "1" @default.
- W2767563585 countsByYear W27675635852020 @default.
- W2767563585 crossrefType "journal-article" @default.
- W2767563585 hasAuthorship W2767563585A5002206377 @default.
- W2767563585 hasAuthorship W2767563585A5005822663 @default.
- W2767563585 hasAuthorship W2767563585A5010517370 @default.
- W2767563585 hasAuthorship W2767563585A5035319804 @default.
- W2767563585 hasAuthorship W2767563585A5040186229 @default.
- W2767563585 hasAuthorship W2767563585A5053437075 @default.
- W2767563585 hasAuthorship W2767563585A5060028789 @default.
- W2767563585 hasAuthorship W2767563585A5060120275 @default.
- W2767563585 hasAuthorship W2767563585A5061712364 @default.
- W2767563585 hasAuthorship W2767563585A5063781367 @default.
- W2767563585 hasAuthorship W2767563585A5088787388 @default.
- W2767563585 hasBestOaLocation W27675635851 @default.
- W2767563585 hasConcept C11960822 @default.
- W2767563585 hasConcept C126322002 @default.
- W2767563585 hasConcept C126838900 @default.
- W2767563585 hasConcept C143409427 @default.
- W2767563585 hasConcept C169760540 @default.
- W2767563585 hasConcept C185592680 @default.
- W2767563585 hasConcept C2779338263 @default.
- W2767563585 hasConcept C2781173314 @default.
- W2767563585 hasConcept C2781197716 @default.
- W2767563585 hasConcept C45664433 @default.
- W2767563585 hasConcept C502942594 @default.
- W2767563585 hasConcept C55493867 @default.
- W2767563585 hasConcept C58693492 @default.
- W2767563585 hasConcept C71924100 @default.
- W2767563585 hasConcept C86803240 @default.
- W2767563585 hasConceptScore W2767563585C11960822 @default.
- W2767563585 hasConceptScore W2767563585C126322002 @default.
- W2767563585 hasConceptScore W2767563585C126838900 @default.
- W2767563585 hasConceptScore W2767563585C143409427 @default.
- W2767563585 hasConceptScore W2767563585C169760540 @default.
- W2767563585 hasConceptScore W2767563585C185592680 @default.
- W2767563585 hasConceptScore W2767563585C2779338263 @default.
- W2767563585 hasConceptScore W2767563585C2781173314 @default.
- W2767563585 hasConceptScore W2767563585C2781197716 @default.
- W2767563585 hasConceptScore W2767563585C45664433 @default.
- W2767563585 hasConceptScore W2767563585C502942594 @default.
- W2767563585 hasConceptScore W2767563585C55493867 @default.
- W2767563585 hasConceptScore W2767563585C58693492 @default.
- W2767563585 hasConceptScore W2767563585C71924100 @default.
- W2767563585 hasConceptScore W2767563585C86803240 @default.
- W2767563585 hasIssue "suppl_6" @default.
- W2767563585 hasLocation W27675635851 @default.
- W2767563585 hasLocation W27675635852 @default.
- W2767563585 hasLocation W27675635853 @default.
- W2767563585 hasOpenAccess W2767563585 @default.
- W2767563585 hasPrimaryLocation W27675635851 @default.
- W2767563585 hasRelatedWork W2016273191 @default.
- W2767563585 hasRelatedWork W2048674585 @default.
- W2767563585 hasRelatedWork W2076738257 @default.
- W2767563585 hasRelatedWork W2748952813 @default.
- W2767563585 hasRelatedWork W2751741310 @default.
- W2767563585 hasRelatedWork W2899084033 @default.
- W2767563585 hasRelatedWork W2983431646 @default.
- W2767563585 hasRelatedWork W4296038731 @default.
- W2767563585 hasRelatedWork W4310484205 @default.
- W2767563585 hasRelatedWork W4381487276 @default.
- W2767563585 hasVolume "19" @default.
- W2767563585 isParatext "false" @default.
- W2767563585 isRetracted "false" @default.
- W2767563585 magId "2767563585" @default.
- W2767563585 workType "article" @default.